Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades.

Sarika HL, Papathoma A, Garofalaki M, Saltiki K, Pappa T, Pazaitou-Panayiotou K, Anastasiou E, Alevizaki M.

Eur J Endocrinol. 2015 Apr;172(4):501-9. doi: 10.1530/EJE-14-0817. Epub 2015 Jan 26.

PMID:
25624014
2.

High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece.

Sarika HL, Papathoma A, Garofalaki M, Vasileiou V, Vlassopoulou B, Anastasiou E, Alevizaki M.

Clin Endocrinol (Oxf). 2012 Dec;77(6):857-62. doi: 10.1111/j.1365-2265.2012.04462.x.

PMID:
22676047
3.

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?

Romei C, Tacito A, Molinaro E, Agate L, Bottici V, Viola D, Matrone A, Biagini A, Casella F, Ciampi R, Materazzi G, Miccoli P, Torregrossa L, Ugolini C, Basolo F, Vitti P, Elisei R.

Clin Endocrinol (Oxf). 2015 Jun;82(6):892-9. doi: 10.1111/cen.12686. Epub 2014 Dec 29.

PMID:
25440022
4.

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.

Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2007 Dec;92(12):4725-9. Epub 2007 Sep 25.

PMID:
17895320
5.

Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.

Wang J, Zhang B, Liu W, Zhang Y, Di X, Yang Y, Yan D.

Fam Cancer. 2016 Jan;15(1):99-104. doi: 10.1007/s10689-015-9828-6.

PMID:
26254625
6.

Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan.

Chang CF, Yang WS, Su YN, Wu IL, Chang TC.

J Formos Med Assoc. 2009 May;108(5):402-8. doi: 10.1016/S0929-6646(09)60084-X.

7.
8.

Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.

Castro MR, Thomas BC, Richards ML, Zhang J, Morris JC.

Thyroid. 2013 Dec;23(12):1547-52. doi: 10.1089/thy.2012.0599. Epub 2013 Jul 25.

PMID:
23461807
10.

Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.

Kihara M, Miyauchi A, Yoshioka K, Oda H, Nakayama A, Sasai H, Yabuta T, Masuoka H, Higashiyama T, Fukushima M, Ito Y, Kobayashi K, Miya A.

Auris Nasus Larynx. 2016 Oct;43(5):551-5. doi: 10.1016/j.anl.2015.12.016. Epub 2016 Feb 1.

PMID:
26837867
11.

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA, Ponder BA.

Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7.

PMID:
7641404
12.

Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.

Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, Roth J, Heitz PU.

Cancer. 1995 Aug 1;76(3):479-89.

PMID:
8625130
13.

Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect.

Fanis P, Skordis N, Frangos S, Christopoulos G, Spanou-Aristidou E, Andreou E, Manoli P, Mavrommatis M, Nicolaou S, Kleanthous M, Cariolou MA, Christophidou-Anastasiadou V, Tanteles GA, Phylactou LA, Neocleous V.

J Endocrinol Invest. 2018 Oct;41(10):1149-1157. doi: 10.1007/s40618-018-0841-0. Epub 2018 Feb 2.

14.

Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma.

Guerrero IM, Pessoa CH, Olmedo DB, Pontes ER, Matos LC, Tilli TM, Barcinski MA, Gimba ER.

Thyroid. 2006 Jan;16(1):9-15.

PMID:
16487008
15.
16.

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.

Zedenius J, Wallin G, Hamberger B, Nordenskjöld M, Weber G, Larsson C.

Hum Mol Genet. 1994 Aug;3(8):1259-62.

PMID:
7987299
17.

Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma.

Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura Y.

J Hum Genet. 1998;43(2):101-6.

PMID:
9621513
18.

[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].

Sansó G, Domené HM, Iorcansky S, Barontini M.

Medicina (B Aires). 1998;58(2):179-84. Spanish.

PMID:
9706252
19.

RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.

Abdelhakim A, Barlier A, Kebbou M, Benabdeljalil N, Timinouni M, Taoufiq F, Roche C, El Antri S.

J Cancer Res Ther. 2009 Jul-Sep;5(3):198-202. doi: 10.4103/0973-1482.57126.

20.

[Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].

Wohllk N, Becker P, Youlton R, Cote GJ, Gagel RF.

Rev Med Chil. 2001 Jul;129(7):713-8. Spanish.

PMID:
11552438

Supplemental Content

Support Center